Morphosys AG v. Cambridge Antibody Technology Ltd.

96 F. App'x 712
CourtCourt of Appeals for the Federal Circuit
DecidedApril 23, 2004
DocketNo. 02-1415
StatusPublished

This text of 96 F. App'x 712 (Morphosys AG v. Cambridge Antibody Technology Ltd.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Morphosys AG v. Cambridge Antibody Technology Ltd., 96 F. App'x 712 (Fed. Cir. 2004).

Opinion

SCHALL, Circuit Judge.

ORDER

The parties move jointly to dismiss and remand to the United States District [713]*713Court for the District of Columbia due to settlement.

The parties request that the court “issue an order remanding the case to the district court for further proceedings leading to an agreed dismissal of the complaint and counterclaim with prejudice.” To the extent that the parties seek vacatur of the district court’s judgment, the parties should request that relief from the district court. See U.S. Bancorp Mortgage Co. v. Bonner Mall P’ship, 513 U.S. 18, 115 S.Ct. 386, 130 L.Ed.2d 233 (1994).

Furthermore, the court notes that it cannot both dismiss and remand the appeal.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The motion to dismiss is denied.

(2) The motion to remand is granted.

(3) Each side shall bear its own costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
96 F. App'x 712, Counsel Stack Legal Research, https://law.counselstack.com/opinion/morphosys-ag-v-cambridge-antibody-technology-ltd-cafc-2004.